Transparency, sustainability and innovation, pillars of the social commitment of the Spanish pharmaceutical industry

The commitment to transparency, contribution to the sustainability of the healthcare system and investment in research and development are the three pillars on which the social commitment of the innovative pharmaceutical industry in Spain is based, according to the local trade group.

Jesus Acebillo, president of Farmaindustria, made this clear during the association’s ordinary general assembly last week, in which the annual report on activities for 2016 and the budget for the current year were approved.

In his speech to the assembly, Mr Acebillo reflected on the challenges facing the sector, highlighting that of transparency, which since last year has involved the publication of companies’ collaborations with health organizations and professionals. “We are on the right track. Transparency is the means to show the need and legitimacy of our collaboration with the health system and its professionals, essential to promote research and the proper use of the medicine, and, in turn, prevent conflicts of interest. And the broad institutional and media support confirms this. With that belief, we must continue to advance, through dialogue with organizations, professionals and patients, to improve this commitment to transparency and to continue to contribute to Spain’s health professionals at the forefront of clinical and scientific knowledge,” he explained.